These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 912965)

  • 21. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs.
    Puglisi TA; Green RW; Hall CL; Read WK; Green RA; Tangner CH; Mann FA; Hobson HP
    Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appearance of Pantopaque on MR images.
    Mamourian AC; Briggs RW
    Radiology; 1986 Feb; 158(2):457-60. PubMed ID: 3753624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR characteristics of iophendylate (Pantopaque).
    Hackney DB; Grossman RI; Zimmerman RA; Joseph PM; Goldberg HI; Bilaniuk LT
    J Comput Assist Tomogr; 1986; 10(3):401-3. PubMed ID: 3486195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complications following myelography with positive contrast media (Pantopaque, Amipaque). Pathomorphologic findings in 2 fatal cases].
    Baessler B; Lahl R
    Zentralbl Neurochir; 1985; 46(2):141-50. PubMed ID: 4060930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and morbidity of water soluble and oil-based myelography. Study compares both methods in 314 patients.
    Dombrowski ET; Rezaian SM; Northcutt C; Boyd W; Fundell L; Anderson C; Malesky E
    Orthop Rev; 1986 Jan; 15(1):24-9. PubMed ID: 3453436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelography with the non-ionic water-soluble contrast medium metrizamide.
    Hindmarsh T
    Acta Radiol Diagn (Stockh); 1975 Sep; 16(5):417-35. PubMed ID: 1199781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.
    Yu YL; du Boulay GH; Paul E
    Neuroradiology; 1986; 28(4):339-43. PubMed ID: 3762912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lumbar myelography: contrast agents used in the past, present, and future.
    Valenti RM
    Radiol Technol; 1987; 58(6):493-6. PubMed ID: 3615840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of metrizamide as a myelographic agent in the dog.
    Stowater JL; Kneller SK
    J Am Vet Med Assoc; 1979 Jul; 175(2):191-5. PubMed ID: 500441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical myelography with a new resorbable contrast medium: Amipaque.
    Gonsette RE
    Acta Neurol Belg; 1976; 76(5-6):283-5. PubMed ID: 1007892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metrizamide for myelography.
    de Villiers PD; Snyman PJ; van Rensburg M
    S Afr Med J; 1980 Mar; 57(13):476-7. PubMed ID: 7368003
    [No Abstract]   [Full Text] [Related]  

  • 36. A prospective clinical trial comparing metrizamide and iohexol for equine myelography.
    Widmer WR; Blevins WE; Jakovljevic S; Levy M; Teclaw RF; Han CM; Hurd CD
    Vet Radiol Ultrasound; 1998; 39(2):106-9. PubMed ID: 9548136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metrizamide for myelography.
    Handler LC
    S Afr Med J; 1980 Feb; 57(6):185-6. PubMed ID: 7361206
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse side effects of metrizamide in myelography.
    Gelmers HJ
    Neuroradiology; 1979 Sep; 18(3):119-23. PubMed ID: 492514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimyelogram in cervical spinal cord trauma.
    Carol M; Ducker TB; Byrnes DP
    Neurosurgery; 1980 Sep; 7(3):219-24. PubMed ID: 7207738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metrizamide myelography for disk disease: continuing need for epidural venography.
    Stephenson TF
    AJNR Am J Neuroradiol; 1981; 2(3):255-9. PubMed ID: 6786060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.